A preserved TGFβ cytostatic response through DLD-mediated metabolic modulation undermines anti-TGFβ therapy in gastric cancer
Yi‐Qian Pan(Sun Yat-sen University), Huai‐Qiang Ju(Sun Yat-sen University), Zerong Cai(Sun Yat-sen University), Zhao-Lei Zeng(Sun Yat-sen University), Xin‐Yuan Guan(Sun Yat-sen University), Yongqiang Zheng(Sun Yat-sen University), Kun Liao, Wenqi Chen(University of Hong Kong - Shenzhen Hospital), Qi‐Nian Wu(Sun Yat-sen University), X M Zhang(Sun Yat-sen University), Yi Han(Sun Yat-sen University), Tian Tian(Qingdao University), Huan Chen(First Affiliated Hospital of Xi'an Jiaotong University), Yue Chen(First Affiliated Hospital of Xi'an Jiaotong University), Yanyu Zhang(Sun Yat-sen University), Yun Li(Nanjing University of Chinese Medicine), Rui‐Hua Xu(Sun Yat-sen University), Haoxiang Wu(Sun Yat-sen University), Zheng-Yu Qian(Sun Yat-sen University), Zexian Liu(Sun Yat-sen University), Tingting Wang(Shantou University), Hai‐long Piao(Dalian Institute of Chemical Physics)
Cited by 2
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868